Moreover, topical application of the mTOR inhibitor rapamycin to AD skin lesions resulted in decreased inflammatory cell infiltration and serum IgE levels, suggesting that inhibition of mTOR signaling suppresses AD [50]. Here, MTOR is linked to Alzheimer disease.